Appointment

Date: 18th June, 2026 To, To, The Manager, The Manager, Department of Corporate Services, Listing Department, BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code:533573 NSE Symbol: APLLTD Dear Sir / Madam, Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations, 2015”) - Appointment of Additional Director (Non-Executive Independent Director) With reference to the captioned matter, we hereby inform that, based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company vide circular resolution passed on 18th June, 2026, has approved the appointment of Mr. Sujit Jaysukh Bhayani (DIN: 01767427) as an Additional Director designated as Non-Executive Independent Director of the Company, with effect from 18th June 2026 for a period of 5 (five) consecutive years, subject to approval of the shareholders at the ensuing Annual General Meeting. We hereby confirm that Mr. Sujit Jaysukh Bhayani is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority. The details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026 is attached herewith as “Annexure-A”. We request you to kindly take the above on record. Thanking you, Yours faithfully, For Alembic Pharmaceuticals Limited Manisha Saraf Company Secretary Encl: A/a ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123 Annexure – A Details under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026: Sr. Particulars Details of Mr. Sujit Jaysukh Bhayani No. (DIN: 01767427) 1 Reason for change Appointment as an Additional Director designated as Non-Executive Independent Director. 2 Date of appointment & Mr. Sujit Jaysukh Bhayani has been appointed w.e.f term of appointment 18th June, 2026, for a period of 5 (Five) years, subject to the approval of shareholders at the ensuing General Meeting and not be liable to retire by rotation. 3 Brief profile (in case of Mr. Sujit Jaysukh Bhayani is the Founder and appointment) Managing Director of the Sudeep Group. Mr. Bhayani holds a Bachelor’s degree in Chemistry from the University of Tulsa and has more than 35 years of experience in the pharmaceuticals industry. He has previously served as a Director of Dinesh Remedies Limited. 4 Disclosure of Mr. Sujit Jaysukh Bhayani is not related to any of the relationships between Directors or Key Managerial Personnel of the Company. directors ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123